Type 1 diabetes (T1D) is a multifactorial autoimmune disease that requires genetic susceptibility as well as environmental triggers such as viral infections in triggering disease onset. One viral infection that is highly correlated with T1D is the Coxsackievirus B (CVB) serotype. Sensing of CVB is mediated by the melanoma differentiation-associated protein 5 (MDA5), a cytosolic sensor of dsRNA, which is encoded by the IFIH1 gene. Stimulation of the MDA5 signaling pathway activates the transcription factors IRF3 and NF-?B p65, which induce Type I IFNs synthesis, which through autocrine signaling initiate an antiviral transcriptional program. Single nucleotide polymorphisms (SNPs) in the IFIH1 gene such as rs1990760, which results in a non-synonymous mutation that changes alanine at position 946 to a threonine, is highly associated with increased risk for T1D. Studies in human PBMCs and mice have demonstrated that the A946T SNP results in an increased sensitivity to viral ligands and subsequently a stronger downstream IFN response. Macrophages have been shown previously to play an important role in T1D initiation, however, the response of ?-cells to viral infection is also important. Our central hypothesis is that T1D-associated SNPs result in an exacerbated islet-resident macrophage immune response and ?-cell inflammatory response following CVB3 infection which contributes to the initiation of autoimmunity. This will be tested using monocyte- derived macrophages and dendritic cells and induced pluripotent stem cells engineered to become human pancreatic ?-cells from healthy donors and patients with T1D that are genotyped for IFIH1 SNPs that contribute to T1D susceptibility and resistance.

Public Health Relevance

Type 1 diabetes is an autoimmune disease where the immune system attacks and destroys the insulin-producing ?-cells in the pancreas. It has been proposed that common viruses that infect children such as Coxsackievirus may play a role in triggering T1D in certain individuals who are already at a high risk of developing disease due to their genetics. In this study, we propose to determine if individuals with mutations in the IFIH1 gene react more strongly to Coxsackievirus infections and environmental stresses of ?-cells, which may be the triggering event for T1D development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK127497-01
Application #
10134042
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Akolkar, Beena
Project Start
2020-09-15
Project End
2024-06-30
Budget Start
2020-09-15
Budget End
2021-06-30
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294